MagForce injects iron oxide nanoparticles into a patient and then vibrates them with a magnetic field to generate heat that helps kill cancer cells. It sounds like science fiction but it’s real. That’s why Peter Thiel’s late-stage investment firm Mithril Capital just led a $15 million investment into MagForce’s new American subsidary that values it at $65 million.